Pharmaceuticals

Prescription Orthopedic Drugs Industry Overview 2025: Growth Projections and Market Trends

November 11, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Future Market Size Estimation For The Prescription Orthopedic Drugs Market Covering 2025–2034?

The prescription orthopedic drugs market size has experienced strong expansion in recent years. It is forecast to grow from $48.41 billion in 2024 to $51.06 billion in 2025, achieving a compound annual growth rate (CAGR) of 5.5%. This historic growth is primarily due to the increased prevalence of musculoskeletal disorders, an expanding geriatric population, heightened awareness regarding osteoporosis treatments, broader healthcare access in developing regions, and a global rise in sports-related injuries.

The market for prescription orthopedic drugs is projected to experience robust expansion in the coming years. This market is set to reach $63.86 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 5.8%. Factors contributing to this growth during the forecast period include the increasing demand for biologics, a rising older adult population, wider access to healthcare in developing regions, the growing occurrence of chronic musculoskeletal conditions, and heightened investment in research and development for orthopedic drugs. Key trends anticipated in the forecast period encompass progress in targeted biologics, the integration of regenerative medicine treatments, customized drug preparations, improvements in less invasive delivery techniques, improved drug effectiveness via gene therapy, new developments in injectable forms, and breakthroughs in artificial intelligence for both drug creation and clinical choices.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21263&type=smp

Which Factors And Drivers Are Influencing The Prescription Orthopedic Drugs Market In 2025?

The expanding occurrence of musculoskeletal disorders is projected to propel the growth of the prescription orthopedic drugs market. Musculoskeletal disorders (MSDs) refer to injuries and conditions that impair the movement and function of the body’s musculoskeletal system, encompassing muscles, tendons, ligaments, nerves, and joints, leading to pain and restricted mobility. The rising prevalence of these disorders largely stems from factors such as aging, work-related activities involving repetitive motions and awkward body positions, lifestyle choices like physical inactivity and poor diet, and genetic predispositions. Prescription orthopedic drugs are crucial for managing MSDs by relieving pain, reducing inflammation, and enhancing recovery, thereby improving mobility and overall quality of life. For example, in March 2023, the Office for Health Improvement and Disparities, a UK-based government department, reported that in 2022, 17.6% of individuals aged 16 and over had a long-term musculoskeletal condition, such as arthritis or persistent back or joint issues, an increase from 17.0% in 2021. Furthermore, in July 2022, the World Health Organization, an intergovernmental organization based in Switzerland, estimated that approximately 1.71 billion people globally suffer from musculoskeletal disorders. Consequently, the escalating incidence of musculoskeletal disorders is a key factor driving the expansion of the prescription orthopedic drugs market.

What Are The Major Segments Identified In The Prescription Orthopedic Drugs Market?

The prescription orthopedic drugs market covered in this report is segmented –

1) By Drug Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Other Drug Types

2) By Application: Osteoarthritis, Rheumatoid Arthritis, Osteoporosis, Other Applications

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Naproxen, Diclofenac, Celecoxib, Indomethacin

2) By Opioids: Morphine, Oxycodone, Hydrocodone, Fentanyl, Tramadol

3) By Corticosteroids: Prednisone, Methylprednisolone, Dexamethasone, Hydrocortisone, Betamethasone

4) By Disease-Modifying Antirheumatic Drugs (DMARDs): Methotrexate, Hydroxychloroquine, Leflunomide, Sulfasalazine, Azathioprine

5) By Other Drug Types: Bisphosphonates, Calcitonin, Monoclonal Antibodies, Muscle Relaxants, Hyaluronic Acid Injections

Which Trends Are Impacting The Prescription Orthopedic Drugs Market?

Companies active in the prescription orthopedic drugs market are concentrating on broadening the approved uses for their medications to expand their market reach, improve patient results, and address unmet medical demands in various orthopedic conditions. For example, in January 2023, Heron Therapeutics Inc., a US-based biotechnology company, gained FDA approval for the extended application of ZYNRELEF (bupivacaine and meloxicam) in soft tissue and orthopedic procedures, encompassing foot and ankle surgeries. This extended-release solution is specifically formulated to deliver prolonged pain alleviation for up to 72 hours, thereby minimizing or negating the need for opioids following surgery. The expanded indication now includes further orthopedic and soft tissue procedures, such as foot and ankle surgeries, thereby enhancing its utility in clinical practice. Its innovative combination of two drugs provides both local anesthetic and anti-inflammatory effects, positioning it as a comprehensive approach for managing post-operative pain with superior patient outcomes.

Which Major Industry Participants Are Leading The Prescription Orthopedic Drugs Market Growth?

Major companies operating in the prescription orthopedic drugs market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck KGaA, AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, GSK Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Biogen Inc., UCB S.A., Allergan plc, Penardo Biotech Pvt. Ltd., Horizon Therapeutics plc

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/prescription-orthopedic-drugs-global-market-report

What Are The Regional Market Dynamics Impacting The Prescription Orthopedic Drugs Industry?

North America was the largest region in the prescription orthopedic drugs market in 2024. The regions covered in the prescription orthopedic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Prescription Orthopedic Drugs Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21263&type=smp

Browse Through More Reports Similar to the Global Prescription Orthopedic Drugs Market 2025, By The Business Research Company

Dermatology Medical Lasers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dermatology-medical-lasers-global-market-report

Dermatology Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dermatology-devices-global-market-report

Veterinary Dermatology Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-dermatology-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795